Eli Lilly Raises Full Year Outlook amid Q2 2023 Profit Surge of 85%
Eli Lilly’s success may be ascribed partially to its promising medical pipeline and strategic acquisitions. American pharmaceutical firm Eli Lilly and Co (NYSE: LLY) has reported a powerful surge in….